3Larrue V, yon Kummer R, M(iller A, et al. Risk factors for severe hemorrhagic transformation in ischemic stroke patients treated with recombinant tissue plasminogen activator a secondary analysis of the European-,lustralasian Acute Stroke Study(ECASS II) [J]. Stroke, 2001, 32 (2): 438-441.